TP53 and liver cancer: Based on the fact that Rb and p53 are frequently inactivated in liver cancers through hepatitis B or C virus infection, reduced xenobiotic metabolism in these livers could influence the efficacy or toxicity of therapeutic drugs or toxins respectively.